Qube Research & Technologies LTD Abbott Laboratories Put Options Transaction History

Qube Research & Technologies LTD

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $7.4 Million - $8.73 Million	-73,900 Reduced 26.57%	204,200 $23.3 Million
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $1.39 Million - $1.55 Million	-13,800 Reduced 4.73%	278,100 $28.9 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $7.17 Million - $7.92 Million	65,500 Added 28.93%	291,900 $33.2 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $414,874 - $507,840	4,600 Added 2.07%	226,400 $24.9 Million
Q3 2023 Nov 13, 2023	BUY	$95.53 - $114.62 $8.34 Million - $10 Million	87,300 Added 64.91%	221,800 $21.5 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $7.51 Million - $8.37 Million	74,500 Added 124.17%	134,500 $14.7 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $8.72 Million - $10.3 Million	-90,000 Reduced 60.0%	60,000 $6.08 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $14.3 Million - $16.7 Million	150,000 New	150,000 $16.5 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $198B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.